Cargando…

The Role of Immunotherapy in the First-Line Treatment of Elderly Advanced Non-Small Cell Lung Cancer

SIMPLE SUMMARY: The treatment of advanced non-small cell lung cancer (NSCLC) after the age of 65 raises age-related problems as the elderly are often affected by other diseases, not infrequently chronic, take drugs that may interfere with anti-cancer treatment and are sometimes unable to fully under...

Descripción completa

Detalles Bibliográficos
Autores principales: Spagnuolo, Alessia, Gridelli, Cesare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136482/
https://www.ncbi.nlm.nih.gov/pubmed/37190247
http://dx.doi.org/10.3390/cancers15082319